García Sergio, Reyes Luis, Roldán Pedro, Torales Jorge, Halperin Irene, Hanzu Felicia, Langdon Cristobal, Alobid Isam, Enseñat Joaquim
Department of Neurosurgery, Hospital Clínic de Barcelona, Barcelona, Spain.
Department of Neurosurgery, Hospital Clínic de Barcelona, Barcelona, Spain.
World Neurosurg. 2017 Jun;102:102-110. doi: 10.1016/j.wneu.2017.02.094. Epub 2017 Feb 27.
To assess the contribution of low-field intraoperative magnetic resonance (iMRI) to endoscopic pituitary surgery.
We analyzed a prospective series of patients undergoing endoscopic endonasal surgery for pituitary macroadenomas assisted with a low-field iMRI (PoleStarN30, 0.15 T [Medtronic]). Clinical, radiologic, and surgical variables were analyzed and compared with our fully endoscopic historic cohort operated on without iMRI assistance. A bibliographic review of pituitary surgery assisted with iMRI was conducted.
Thirty patients (57% female; mean age, 55 years) were prospectively analyzed. The most frequent tumor subtype was nonfunctioning macroadenoma (50%). The average Knosp grade was 2.3 and mean tumor size was 18 mm. Surgical and positioning time were 102 and 47 minutes, respectively. Hospital stay and complication rates were similar to our historical cohort for pituitary surgery. Mean follow-up was 10 months. Complete resection (CR) was achieved in 83% of patients. Seven patients (23%) benefited from iMRI assistance and achieved a CR in their surgeries. All patients except 1 experienced hormonal activity remission. iMRI sensitivity and specificity was 0.8 and 1, respectively. Although not statistically significant, CR rates were globally 11.5% superior in iMRI series compared with our historical cohort. This difference was independent of cavernous sinus invasiveness grade (CR rate increased 12.5% for Knosp grade 0-2 and 8.1% for Knosp grade 3-4).
Low-field iMRI is a useful and safe assistance even in advanced surgical techniques such as endoscopy. Its contribution is limited by the intrinsic features of the tumor. Further randomized studies are required to confirm the cost-effectiveness of iMRI in pituitary surgery.
评估低场术中磁共振成像(iMRI)在内镜下垂体手术中的作用。
我们分析了一系列接受低场iMRI(PoleStarN30,0.15T[美敦力公司])辅助的经鼻内镜垂体大腺瘤手术的前瞻性患者。对临床、放射学和手术变量进行分析,并与我们未使用iMRI辅助的全内镜历史队列进行比较。对iMRI辅助的垂体手术进行了文献综述。
对30例患者(57%为女性;平均年龄55岁)进行了前瞻性分析。最常见的肿瘤亚型是非功能性大腺瘤(50%)。平均Knosp分级为2.3,平均肿瘤大小为18mm。手术时间和定位时间分别为102分钟和47分钟。住院时间和并发症发生率与我们垂体手术的历史队列相似。平均随访时间为10个月。83%的患者实现了完全切除(CR)。7例患者(23%)受益于iMRI辅助并在手术中实现了CR。除1例患者外,所有患者的激素活性均得到缓解。iMRI的敏感性和特异性分别为0.8和1。尽管无统计学意义,但iMRI系列的CR率总体上比我们的历史队列高11.5%。这种差异与海绵窦侵袭分级无关(Knosp 0-2级的CR率提高12.5%,Knosp 3-4级的CR率提高8.1%)。
即使在诸如内镜等先进手术技术中,低场iMRI也是一种有用且安全的辅助手段。其作用受肿瘤固有特征的限制。需要进一步的随机研究来证实iMRI在垂体手术中的成本效益。